Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Vanslembrouck
Long-Term Expression of Human Coagulation Factor VIII and Correction of Hemophilia a After in Vivo Retroviral Gene Transfer in Factor VIII-deficient Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Heterozygous Antithrombin Deficiency Improves in Vivo Haemostasis in Factor VIII-deficient Mice
Thrombosis and Haemostasis
Hematology
Expression of Human Coagulation Factor VIII in Adipocytes Transduced With the Simian Immunodeficiency Virus agmTYO1-based Vector for Hemophilia a Gene Therapy
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
A Long-Term, Multi-Center Clinical Study of Recombinant Human Factor VIII BAY W 6240) in Treatment of Hemophilia A.
Journal of the Japan Society of Blood Transfusion
Survival of 125iodine-Labeled Factor VIII in Normals and Patients With Classic Hemophilia. Observations on the Heterogeneity of Human Factor VIII.
Journal of Clinical Investigation
Medicine
Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A
Journal of Medical Science And Clinical Research
652. Long-Term Follow-Up of Hemophilia a Dogs for 2-7 Years Demonstrates Sustained Factor VIII Expression After AAV-Mediated Delivery
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice
Journal of Pharmaceutical Sciences
Pharmaceutical Science
Management of Coagulation Factor VIII (FVIII) Inhibitors
Thrombosis Research
Hematology
